Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ digital
    • Subscribe to CMAJ print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ digital
    • Subscribe to CMAJ print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Editorial

Cannabis legislation fails to protect Canada’s youth

Diane Kelsall
CMAJ May 29, 2017 189 (21) E737-E738; DOI: https://doi.org/10.1503/cmaj.170555
Diane Kelsall
Editor-in-Chief [interim], CMAJ
MD MEd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

With tabling of Bill C-45, the federal government has moved one step closer to fulfilling its election promise to legalize the use of cannabis in Canada, despite concerns over the many health risks associated with its use. The purported purpose of the act is to protect public health and safety,1 yet some of the act’s provisions appear starkly at odds with this objective, particularly for Canada’s youth.

Simply put, cannabis should not be used by young people. It is toxic to their cortical neuronal networks, with both functional and structural changes seen in the brains of youth who use cannabis regularly.2 The Centre for Addiction and Mental Health has stated unequivocally that “cannabis is not a benign substance and its health harms increase with intensity of use.”3 Although adults are also susceptible to the harmful effects of cannabis, the developing brain is especially sensitive. The Canadian Paediatric Society cautions that marijuana use in youth is strongly linked to “cannabis dependence and other substance use disorders; the initiation and maintenance of tobacco smoking; an increased presence of mental illness, including depression, anxiety and psychosis; impaired neurological development and cognitive decline; and diminished school performance and lifetime achievement.”2 The lifetime risk of dependence on marijuana is about 9%; however, this increases to almost 17% in those who start using as teenagers.4

Bill C-45 draws on the work of the federal Task Force on Cannabis Legalization and Regulation that recommended taking a public health approach to the regulation of cannabis to minimize associated harms.5 Yet, in the bill, the federal government has set the national minimum age for purchase of marijuana at 18 years with no limits on potency and allows for personal cultivation of cannabis for nonmedical purposes.1 Failure to set national standards for distribution also opens the door to substantial variation in ease of access.

Drawing on current evidence that suggests that the human brain appears to mature until about age 25 years, the Canadian Medical Association (CMA), in its response to the federal task force report, recommended that the minimum age of purchase and consumption be set at 21 years.4 Along with others, the CMA also called for restricting cannabis quantities and potency for those under the age of 25 years, because higher potency increases the risk of adverse effects.2–4 These pragmatic recommendations balance protection of the developing brain with the hope of reducing use of illicit cannabis among youth.

The federal government has stepped back from setting national standards for retail distribution systems.1 Because provinces and territories are mandated to set their own regulations, ease of access to cannabis will likely differ across the country and include various combinations of mail order, online sales, storefront shops, liquor stores and other modes of access. These differences will complicate enforcement, particularly at jurisdictional borders, and may contribute to diversion. And it is naive to think that organized crime will not be involved in the legal production and distribution of cannabis with the passing of Bill C-45, because it is already implicated in the medical marijuana industry.6

Bill C-45 allows for personal cultivation of up to four marijuana plants, each no more than 1 m in height.1 Because marijuana plants can grow to a height of 6 m, the height restriction will substantially reduce each plant’s yield (although shorter cultivars are sure to be in the offing). However, allowing personal cultivation will increase the risk of diversion and access to cannabis that is not subject to any quality or potency controls.6 This is not consistent with the act’s goals of establishing strict safety and quality requirements for cannabis and restricting its access to youth.1 In addition, allowing personal cultivation places pressure on law enforcement officials in interpreting and enforcing these regulations.6

Most of us know a young person whose life was derailed because of marijuana use. Bill C-45 is unlikely to prevent such tragedies from occurring — and, conversely, may make them more frequent. Although an accompanying bill lays out stronger penalties for impaired driving and proposed limits for blood levels of tetrahydrocannabinol in drivers, there is grave concern that legalization of marijuana will result in a substantial increase in impaired driving, particularly among young people and in conjunction with alcohol use.6

The government appears to be hastening to deliver on a campaign promise without being careful enough about the health impacts of policy. It’s not good enough to say that provinces and territories can set more stringent rules if they wish. If Parliament truly cares about the public health and safety of Canadians, especially our youth, this bill will not pass.

Footnotes

  • Competing interests: See www.cmaj.ca/site/misc/cmaj_staff.xhtml

References

  1. ↵
    Bill C-45. First Session, Forty-second Parliament, 64-65-66 Elizabeth II, 2015–2016–2017. Available: www.parl.gc.ca/content/hoc/Bills/421/Government/C-45/C-45_1/C-45_1.PDF (accessed 2017 May 7).
  2. ↵
    Cannabis and Canada’s children and youth [position statement]. Ottawa: Canadian Paediatric Society; 2016. Available: www.cps.ca/en/documents/position/cannabis-children-and-youth (accessed 2017 May 7).
  3. ↵
    Cannabis Policy Framework. Toronto: Centre for Addiction and Mental Health; 2014. Available: www.camh.ca/en/hospital/about_camh/influencing_public_policy/documents/camhcannabispolicyframework.pdf (accessed 2017 May 7).
  4. ↵
    Legalization, regulation and restriction of access to marijuana. Ottawa: Canadian Medical Association; 2016. Available: www.cma.ca/Assets/assets-library/document/en/advocacy/submissions/2016-aug-29-cma-submission-legalization-and-regulation-of-marijuanae.pdf (accessed 2017 May 7).
  5. ↵
    A framework for the legalization and regulation of cannabis in Canada: the final report of The Task Force on Cannabis Legalization. Ottawa: Health Canada; 2016.
  6. ↵
    CACP discussion paper — recommendations of the Task Force on Cannabis Legalization and Regulation, February 8, 2017. Kanata (ON): Canadian Association of Chiefs of Police; 2017. Available: https://cacp.ca/news/cacp-discussion-paper-recommendations-for-the-task-force-on-cannabis-legalization-and-regulation-feb.html (accessed 2017 May 7).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 189 (21)
CMAJ
Vol. 189, Issue 21
29 May 2017
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cannabis legislation fails to protect Canada’s youth
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cannabis legislation fails to protect Canada’s youth
Diane Kelsall
CMAJ May 2017, 189 (21) E737-E738; DOI: 10.1503/cmaj.170555

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Cannabis legislation fails to protect Canada’s youth
Diane Kelsall
CMAJ May 2017, 189 (21) E737-E738; DOI: 10.1503/cmaj.170555
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Cannabis prohibition harms Canada’s youth
  • Cannabis use, legalization and youth health
  • PubMed
  • Google Scholar

Cited By...

  • Cannabis prohibition harms Canadas youth
  • Cannabis use, legalization and youth health
  • Google Scholar

More in this TOC Section

  • Addressing fragmented early pregnancy care in Canada
  • New CMAJ article type aims to help physicians support their patients
  • Time to treat the climate and nature crisis as one indivisible global health emergency
Show more Editorial

Similar Articles

Collections

  • Topics
    • Cannabis

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire